BCB
Brian C. Broderick Portfolio holdings
AUM
$506M
This Quarter Return
-3.24%
1 Year Return
+12.39%
3 Year Return
+70.69%
5 Year Return
+110.99%
10 Year Return
+270.67%
AUM
$320M
AUM Growth
+$320M
(-3%)
Cap. Flow
+$18.3M
Cap. Flow
% of AUM
5.7%
Top 10 Holdings %
Top 10 Hldgs %
39.2%
Holding
79
New
8
Increased
24
Reduced
29
Closed
–
Top Buys
| 1 |
Medtronic
MDT
|
$543K |
| 2 |
UnitedHealth
UNH
|
$432K |
| 3 |
NVIDIA
NVDA
|
$420K |
| 4 |
CrowdStrike
CRWD
|
$330K |
| 5 |
Zscaler
ZS
|
$329K |
Top Sells
| 1 |
3M
MMM
|
$542K |
| 2 |
Canadian National Railway
CNI
|
$277K |
| 3 |
Honeywell
HON
|
$252K |
| 4 |
Union Pacific
UNP
|
$195K |
| 5 |
Novartis
NVS
|
$150K |
Sector Composition
| 1 | Technology | 23.7% |
| 2 | Healthcare | 23.3% |
| 3 | Industrials | 13.02% |
| 4 | Consumer Discretionary | 8.56% |
| 5 | Consumer Staples | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
NVIDIA
NVDA
$4.15T
| $4.61M | 1.44% |
37,953
+3,459
| +10% | +$420K |
|
27
PepsiCo
PEP
$203B
| $3.8M | 1.19% |
23,265
-610
| -3% | -$99.6K |
|
28
Edwards Lifesciences
EW
$47.7B
| $3.77M | 1.18% |
45,653
+3,650
| +9% | +$302K |
|
29
Chevron
CVX
$318B
| $3.73M | 1.17% |
25,954
-284
| -1% | -$40.8K |
|
30
Nike
NKE
$110B
| $3.37M | 1.05% |
40,576
+1,416
| +4% | +$118K |
|
31
Exxon Mobil
XOM
$477B
| $3.12M | 0.97% |
35,725
-164
| -0.5% | -$14.3K |
|
32
Illumina
ILMN
$15.2B
| $2.86M | 0.9% |
15,012
-250
| -2% | -$47.7K |
|
|
33
Medtronic
MDT
$118B
| $2.8M | 0.88% |
34,727
+6,722
| +24% | +$543K |
|
|
34
Novartis
NVS
$248B
| $2.31M | 0.72% |
30,405
-1,980
| -6% | -$150K |
|
35
Church & Dwight Co
CHD
$22.7B
| $2.22M | 0.69% |
31,128
+3,235
| +12% | +$231K |
|
36
Aptiv
APTV
$17.3B
| $1.83M | 0.57% |
23,347
+2,720
| +13% | +$213K |
|
37
AbbVie
ABBV
$374B
| $1.75M | 0.55% |
13,012
-225
| -2% | -$30.2K |
|
38
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11B
| $1.32M | 0.41% |
30,000
| – | – |
|
39
Welltower
WELL
$112B
| $1.19M | 0.37% |
18,500
+3,500
| +23% | +$225K |
|
40
Bristol-Myers Squibb
BMY
$96.7B
| $832K | 0.26% |
11,700
| – | – |
|
41
Ironwood Pharmaceuticals
IRWD
$201M
| $818K | 0.26% |
79,000
-4,500
| -5% | -$46.6K |
|
42
Pembina Pipeline
PBA
$21.9B
| $665K | 0.21% |
21,901
-399
| -2% | -$12.1K |
|
43
Becton Dickinson
BDX
$54.3B
| $663K | 0.21% |
2,976
-290
| -9% | -$64.6K |
|
44
Trane Technologies
TT
$90.9B
| $575K | 0.18% |
3,970
| – | – |
|
45
Thermo Fisher Scientific
TMO
$183B
| $545K | 0.17% |
1,075
| – | – |
|
46
Intel
INTC
$105B
| $534K | 0.17% |
20,740
-1,250
| -6% | -$32.2K |
|
47
Merck
MRK
$210B
| $487K | 0.15% |
5,650
| – | – |
|
48
Novo Nordisk
NVO
$252B
| $452K | 0.14% |
4,535
-165
| -4% | -$16.4K |
|
49
Coca-Cola
KO
$297B
| $407K | 0.13% |
7,280
| – | – |
|
50
ConocoPhillips
COP
$118B
| $401K | 0.13% |
3,919
| – | – |
|